Active Internal Calls for Limited Submission Nominations
No current opportunities
Active Internal Calls for NON-Limited External Nominations
Applications due July 24, 2017
From transplanting cells to regenerating damaged nerve fibers to designing adaptive canoe seats, the Paralyzed Veterans of America Research Foundation supports innovative research and fellowships that improve the lives of those with spinal cord injury and disease (SCI/D). The Research Foundation, a 501(c)(3) nonprofit, funds the following categories:
Laboratory research in the basic sciences to find a cure for SCI/D
Clinical and functional studies of the medical, psychosocial and economic effects of SCI/D, and interventions to alleviate these effects
Design and development of assistive technology for people with SCI/D, which includes improving the identification, selection and utilization of these devices
Fellowships for postdoctoral scientists, clinicians and engineers to encourage training and specialization in the field of spinal cord research
BEFORE YOU APPLY
The Research Foundation is focused on funding projects grounded in basic laboratory science and the education of scientists working on breakthroughs directed toward a cure for paralysis or the secondary medical conditions, and technologies associated with spinal cord injury or disease (SCI/D). These projects should be designed to find better treatments and cures for paralysis, to support efforts to improve the quality of life of individuals with SCI/D until improved clinical treatments, technologies or cures are discovered, and to train post-doctoral fellow investigators and encourage them to specialize in the area of spinal cord research.
Before submitting a grant application, carefully read the Research Foundation's Policies and Procedures as policies may change from year to year.
Eligible grantee institutions must be located in the United States or Canada. However, investigators and fellows are not required to be U.S. or Canadian citizens. All grant applicants must have a professional degree: Ph.D. or M.D. preferred, master’s degree acceptable under some circumstances.
Senior fellows are encouraged to apply as principal investigators. Post-doctoral individuals are eligible to apply for fellowship support within four years of receiving a Ph.D. or completing M.D. residency. Graduate students can participate in Foundation-related research and be paid from a Foundation award. However, graduate students cannot apply for a Foundation grant either as a fellow or as a principal investigator.
Patient-Centered Outcomes Research Institute (PCORI)'s Symptom Management for Patients with Advanced Illness - Cycle 2 2017
LOIs due July 25, 2017
PCORI seeks to fund multiple high-quality clinical studies that compare the effectiveness of evidence-based treatments for relief of common symptoms experienced by patients living with advanced illness. The goal of this initiative is to support patient- and caregiver-centered comparative clinical effectiveness research (CER) to generate important findings that will aid clinical decision making for symptom management. The proposed interventions must include an evidence-based pharmacological treatment and one or more appropriate pharmacological or non-pharmacological interventions that reflect the decision making and choices in contemporary clinical practice. This PFA is specifically focused on the following symptoms:
- Depression and/or anxiety
This PFA is targeted toward advanced illnesses such as (but not limited to) advanced heart failure, advanced cancer, chronic obstructive pulmonary disease, end-stage liver and kidney disease, or neurodegenerative diseases. Studies on populations with advanced illnesses other than cancer, which have not been heavily represented in prior research, are of particular interest. This PFA is not limited to any age group, although PCORI is interested in increasing evidence in pediatric and adolescent disease populations where fewer studies exist. We encourage applicants to include assessments of caregiver outcomes where appropriate (e.g., in studies of pediatric and adolescent populations).
PCORI has allotted up to $25 million in total costs under this PFA to fund multiple high-quality and impactful studies related to treating symptoms in advanced illness populations. The proposed budget for studies under this initiative may be up to $2 million in direct costs as appropriate. The maximum project period is three years. PCORI may consider funding larger studies if investigators submit a strong rationale at the Letter of Intent (LOI) stage.
For more information regarding eligibility and submission instructions, please visit the Institute's website.
Applications due August 14th
The Beckman Young Investigator (BYI) Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science.
- Projects proposed for the BYI program should be truly innovative, high-risk, and show promise for contributing to significant advances in chemistry and the life sciences. They should represent a departure from current research directions rather than an extension or expansion of existing programs. Proposed research that cuts across traditional boundaries of scientific disciplines is encouraged. Proposals that open new avenues of research in chemistry and life sciences by fostering the invention of methods, instruments and materials will be given additional consideration.
- The BYI program funds promising young scientists early in their careers who have not yet received a major award from another organization. Proposals that already have substantial funding will not be considered for the BYI award (see eligibility for more information).
- Projects are normally funded for a period of four years. Grants are in the range of $600,000 over the term of the project, contingent upon demonstrated progress after the second year of the award.
- The Foundation does not provide for overhead or for indirect costs.
- The BYI program is open to those within the first three years of a tenure-track position, or an equivalent independent research appointment, at a United States academic or non-profit institution that conducts research in chemical and life sciences. Tenure Track Start Date must be after: 8/14/2014
- Candidates must be citizens or permanent residents of the United States at the time of application. Persons who have applied for permanent residency but have not received their government documentation by the time of application are not eligible.
- No individual may apply for a Beckman Young Investigator award more than two times.
- Investigators can have no more than $225,000 in direct, annualized external funding grants during any BYI Program Year (Aug-July) at time of application. Start-up funds, department-wide instrumentation grants, and "Transition" grants (such as NIH K99/R00) are not counted toward this total.
Visit the foundation's website for full application guidelines. Interested applicants, please contact Adele White in Corporate and Foundation Relations.
Applications due August 29th
The Harrington Prize for Innovation in Medicine, presented by the American Society for Clinical Investigation and the Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development – honors a physician-scientist who has moved science forward with notable achievements in innovation, creativity and potential for clinical application.
This annual prize includes:
- An unrestricted $20,000 honorarium
- The Harrington Prize Lecture, delivered at the 2018 AAP/ASCI/APSA Joint Meeting
- Participation at the Harrington Discovery Institute Annual Symposium
- A personal essay, published in the Journal of Clinical Investigation
- Must hold an MD or equivalent degree
- Need not be an ASCI member
- No age or citizenship requirement
- Self-nomination is not permitted
- Must be available to deliver a lecture at the AAP-ASCI-APSA Joint Meeting
- Must submit a personal essay for publication in the Journal of Clinical Investigation
Submissions due August 31st
The Federation of American Societies for Experimental Biology (FASEB) announces its sixth annual BioArt competition. Help celebrate the artistic side of science by sharing a glimpse into your cutting-edge research!
Each day, scientific investigators produce thousands of images and videos as part of their research. However, only a few are seen outside the laboratory. Through the BioArt competition, FASEB aims to share the beauty and excitement of biological research with the public. Past winning images have been displayed at the National Institutes of Health and other venues!
Entries are welcome from individuals and research teams that either receive U.S. federal funding or include at least one member of a FASEB society. Submissions should be products of a research project.
New Image Category
New to this competition cycle is an image category for 3D printing. Through this special focus, FASEB hopes to highlight the many different applications of this technology in biological research. Winners will be selected from this new category as well as from the contest’s long-standing image and video categories.
More Information and Resources
For more information, visit the BioArt website or email the BioArt team at BioArt@faseb.org
LOIs due September 7, 2017
The Conquer Cancer Now Award is a $60,000 grant given to young and innovative cancer researchers focused on cancer genetics, cancer biology and cancer immunology. Approximately 20 researchers receive a $60,000 Conquer Cancer Now Award per year for the two-year grant cycle. The Concern Foundation is now accepting LOI's through September 7th, 2017.
Grants are awarded to independent investigators who are at the start of their scientific career (i.e., junior faculty) and are at the level of Assistant Professor (or equivalent with explanation). A letter from the applicant's Department Chair is required and should attest to
- the applicant's faculty status
- the applicant's status as an independent investigator
- institutional support in terms of stand-alone laboratory space and startup funds
- percent protected time devoted to research as junior faculty.
This letter needs to accompany the initial Letter of Intent and (if selected) also uploaded with the full proposal.
Priority is given to proposals from independent investigators who have yet to obtain significant funding for their work. Applicant who is PI on an existing R01 or equivalent is not eligible. Applicant who is notified prior to the full Concern grant submission deadline of a clearly fundable score on an R01 or equivalent grant-in-review where he/she is PI is also not eligible. However, a submitted R01 that has not yet been reviewed at the time of Concern grant submission is eligible. If its score is not clearly fundable in this interim period, contact Concern to determine eligibility.
Applicants must list all current and pending support from other funding sources, noting any budgetary or scientific overlap. This includes funding from all years of multi-year grants. This information will be requested with the initial LOI and will need to be updated with the full grant application.
Concern Foundation accepts grant applications from institutions in the United States and abroad. U.S. citizenship is not a requirement.
Applicants at governmental agencies are not eligible.
The total grant amount for a Conquer Cancer Now Award is $60,000 per year for a maximum of two years. A second year of funding is not guaranteed and is based on evidence of sufficient progress based on the required progress report, availability of funds, and approval of the Concern Foundation Executive Board. Grants are disbursed in quarterly installments.
Applications due September 8, 2017
The program is designed to support innovative translational research projects in hematology/oncology, with a focus on hematologic malignancies, that can be either based around a clinical trial with strong correlative science or laboratory investigation.
Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no direct overlap in funding.
This award is intended for junior faculty who are in the early stages of their career and are planning to become independent investigators.
Applicants must meet the following requirements:
- Hold an MD, DO, PhD, or equivalent degree at time of award
- Be within 5 years of initial faculty appointment in association with an academic research institution in the United States or Canada at the time of application
- Have a strong career interest in hematology/oncology, with a focus on hematologic malignancies
- Have a research mentor with extensive experience in the field of hematology/oncology, with a focus on hematologic malignancies
- Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
- Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects
An applicant must be a citizen or permanent resident of the United States or Canada or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2018 – December 31, 2019).
Lung Cancer Foundation of America (LCFA) & the International Association for the Study of Lung Cancer's (IASLC) Lori Monroe Scholarship in Translational Lung Cancer Research
Applications due September 15th
This joint LCFA/IASLC initiative will award:
- 2 Lung Cancer Research Grants
- $200,000 each grant
- Over 2 years
Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC) seek applications for the Lori Monroe Scholarship in Lung Cancer Research Awards.
Applications addressing the following research areas will be given priority:
- Facilitating the collaboration, information-sharing and interaction between basic researchers and clinical investigators with the goal of expediting and translating results of scientific investigation into clinical practice to reduce the burden of lung cancer; or
- Exploring innovative models of lung cancer care delivery; or
- Exploring the etiologies of lung cancer in the never smoker population.
The objective of this Award is to support research that improves the care of individuals with lung cancers and to reduce the burden of these diseases. Examples include studies:
- designed to define the molecular bases of lung cancer risk assessment;
- to improve molecular diagnostic studies designed to detect the lung cancer early and guide curative-intent therapy;
- predictive features guiding the use of targeted or immune oncology therapy to reduce recurrence after standard curative-intent strategies in early stage disease;
- or to improve the outcomes or cure patients with metastatic lung cancer. Studies designed to facilitate care by minimizing treatment side effects or illuminating the causes of nonsmoking related lung cancer are encouraged, as well.
Submissions due October 1st
The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared towards researchers focused on basic or translational research that advances regenerative medicine and cell therapy. Established in 2017, the prize is awarded for outstanding research performed by the applicant and as a mutual endeavour to raise awareness for the field and its fundamental significance for our future.
The winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is awarded US$25,000 and a publication of his or her essay in Science. This Grand Prize essay and those of up to three runners-up are also published on Science Online. The winner and the runners-up are invited to the award ceremony. Furthermore, a 5-year AAAS membership and online subscription to Science, accompanied by attractive product packages from Sartorius, are awarded!
Awarded fields: Entries can be made in the fields of regenerative medicine, cell therapy, gene therapy, immunotherapy as well as materials and tissue engineering.
Eligibility: Every individual scientist who received his or her PhD|MD within the past 10 years may apply.
Required documents: Please submit a 1,000-word essay describing your research and its implications for regenerative medicine and cell immunotherapy as well as supporting documents.
Proposals due October 2nd
This grant funds groundbreaking or unconventional methodologies, whose risky outlook is justified by the possibility of a major breakthrough for Inflammatory Bowel Disease (IBD). The spirit of this award is to forge partnerships and collaborations in the field of IBD research.
Synergy Award Details
- Grant Amount: $100,000 USD in research support to each investigator on the team, up to a total of $300,000 USD. Funding is for one year.
- Proposals Accepted Online: June 2–October 2. Applications must demonstrate that the end product of the proposed research could not be achieved without collaboration.
- Eligibility, Budget Guidelines & How to Apply: krfoundation.org/synergy-award
Basic Science: If your research proposal is rooted in basic science, we encourage you to collaborate with investigators who can further the potential for translation of your ideas and findings.
Translational Science: If your research proposal is translational by nature, we encourage you to identify industry and clinical partners to assist in propelling your research toward clinical study.
Clinical Science: If you are looking to submit a clinical research proposal, we encourage you to collaborate with individuals who could facilitate potential clinical implementation.
Berliner Institut Für Gesundheits Forschung's Excellence Award for Sex and Gender Aspects in Health Research
Applications due October 15th
BIH in cooperation with the Institute of Gender in Medicine (GiM) announces the “BIH Excellence Award for Sex and Gender Aspects in Health Research”. The award aims to bring more visibility to sex and gender issues in translational research. It recognizes research excellence among renowned scientists working in the field of basic and/or clinical biomedical research with a focus on sex and gender aspects.
To be eligible for participation in this competition, applicants must:
- be a renowned scientist in the field of basic or clinical biomedical research
- have made significant contributions to translational research with high relevance to the mission and strategy of BIH
- have a focus on sex and gender aspects in their research, which means, that sex and/or gender must be an integral aspect of the applicant’s research approach and design
- develop and provide a concise research program proposal for a visiting fellowship in Berlin that is of strategic relevance to BIH and has a focus on sex and/or gender aspects in research
How to Apply
Applications for the BIH Award must be submitted electronically via the BIH application portal at https://portal.bihealth.de/portal/SitePages/Portal.aspx
(We are sorry to announce that we have technical problems with the portal at the moment, but it should work within the next days; the latest Thursday July 20, 2017).
Please provide the following documents as a single PDF upload:
- CV including the 5–10 most important publications
- Motivation letter describing your achievements and the impact of those achievements in the field of translational research with a focus on sex and gender aspects
- Exposé of the planned cooperation with scientists in Berlin and the planned research program
- 2 reference letters
For more information concerning the Einstein BIH Visiting Fellowship and the BIH Visiting Professor please visit this page.